Table 2. Comparison of patients by Metavir score.

Characteristics	Testing Set (n= 108)			Validation Set (n= 324)
	Non-cirrhosis (n= 73)	Cirrhosis (n= 35)	P	Non-cirrhosis (n= 192)	Cirrhosis (n = 132)	P
Age	50±11.75	54±11	0.121	52±12	54±11	0.163
Gender (male v female)	60 v 13	25 v 10	0.785	162 v 30	114 v 18	0.621
ALT (U/L)	46.93±39.66	56.06±49.39	0.344	58.66±91.54	62.06±103.14	0.012
AST (U/L)	42.79±25.24	62.77±36.78	<0.001	46.61±60.35	46.83±38.06	0.002
TB (mg/dL)	0.95±0.59	1.19±0.62	0.009	0.88±0.66	1.00±0.65	0.039
ALB (g/L)	41.51±6.84	39.37±5.99	0.102	44.39±4.61	42.29±4.50	<0.001
Creatinine (mg/dL)	0.74±0.17	0.86±0.21	0.004	0.90±0.55	0.94±0.47	0.452
AFP (ng/ml) (≤20 v >20)	31 v 42	17 v 18	0.552	70 v 122	56 v 76	0.280
HBV DNA level (≤105 v >105copies/ml)	34 v 39	15 v 20	0.837	79 v 113	50 v 82	0.566
INR	1.04±0.013	1.13±0.016	0.005	1.00±0.07	1.05±0.09	<0.001
Platelet count (109/L)	156.22±61.69	106.66±63.70	0.001	157.59±58.77	124.89±64.82	<0.001
Tumor number (single v multiple)	55 v 18	30 v 5	0.220	172 v 20	111 v 21	0.145
Vascular invasion (yes v no)	28 v 45	20 v 15	0.067	54 v 138	30 v 102	0.277
Tumor encapsulation (yes v no)	17 v 56	5 v 30	0.279	108 v 84	68 v 64	0.401
Tumor size (≤5.0 v >5.0)	35 v 38	13 v 22	0.293	123 v 69	100 v 32	0.028
TNM stage (I-II v III A)	39 v 34	16 v 19	0.455	155 v 37	122 v 10	0.785
Postoperative TACE (yes v no)	30 v 43	15 v 20	0.621	62 v 130	54 v 78	0.767
Re-operation (yes v no)	6 v 67	5 v 30	0.469	16 v 176	12 v 120	0.812

Abbreviations: HBV: hepatitis B virus; HCC: hepatocellular carcinoma; ALT: alanine aminotransferase; AST: aspartate aminotransferase; TB: total bilirubin; ALB: Albumin; INR: international normal ratio; AFP: alpha fetoprotein; TACE: transarterial chemoembolization.